Showing results (331-340 of 357) with videos related to
Sort By:
Pageof 36
The American Journal of Cardiology|November 23, 1976
Renin and aldosterone suppression in the antihypertensive action of clonidineM A Weber, D B Case, L Baer, et al.Archives of Internal Medicine|February 27, 1995
Blood pressure effects of the angiotensin II receptor blocker, losartanM A Weber, R L Byyny, J H Pratt, et al.American Heart Journal|August 1, 1995
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatmentL M Prisant, M R Weir, V Papademetriou, et al.Journal of Hypertension|May 1, 1994
A repressive coping style protecting from emotional distress in low-renin essential hypertensivesC Perini, D H Smith, J M Neutel, et al.Der Radiologe|March 3, 2004
[Noninvasive measurement of relative cerebral blood flow with the blood bolus MRI arterial spin labeling: basic physics and clinical applications]M-A Weber, A Kroll, M Günther, et al.The American Journal of Cardiology|December 15, 1990
Low-dose aspirin versus anticoagulants for prevention of coronary graft occlusionM A Weber, J Hasford, C Taillens, et al.Journal of Human Hypertension|August 1, 1994
Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertensionW D Hall, M A Weber, K Ferdinand, et al.Journal of the American College of Cardiology|September 1, 1988
Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)K L Neuhaus, U Tebbe, M Gottwik, et al.Klinische Wochenschrift|January 1, 1988
[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]K L Neuhaus, U Tebbe, M Gottwik, et al.Archives of Internal Medicine|March 1, 2000
Implications of a health lifestyle and medication analysis for improving hypertension controlM R Weir, E W Maibach, G L Bakris, et al.Pageof 36